Evidence map›Paper›PMID 38509817›Full record

Observational studyESC heart failure2024

Cardiovascular disease healthcare trajectories: descriptions, similarities, mortality rates of heart failure in France.

Camille Nevoret, Yohann Tran, Soulef Guendouz, Audrey Lavenu, Sandrine Katsahian, Thibaud Damy, Anne-Isabelle Tropeano

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Camille NevoretCEMKA, Bourg-la-Reine, France.
Yohann TranClinical Research Unit, CIC-EC 1418, European Hospital Georges-Pompidou, APHP, Paris, France.
Soulef GuendouzReferral Center for Cardiac Amyloidosis, Mondor Amyloidosis Network, GRC Amyloid Research Institute and Cardiology Department, INSERM Unit U955, Team 8, Paris-Est Creteil University, Hospital Henri Mondor, Val-de-Marne, Créteil, France.
Audrey LavenuUniv Rennes, CIC 1414 INSERM, IRMAR, Mathematics Institute of Rennes CNRS, Rennes, France.
Sandrine KatsahianClinical Research Unit, CIC-EC 1418, European Hospital Georges-Pompidou, APHP, Paris, France.
Thibaud DamyReferral Center for Cardiac Amyloidosis, Mondor Amyloidosis Network, GRC Amyloid Research Institute and Cardiology Department, INSERM Unit U955, Team 8, Paris-Est Creteil University, Hospital Henri Mondor, Val-de-Marne, Créteil, France.
Anne-Isabelle TropeanoClinical Research Unit, CIC-EC 1418, European Hospital Georges-Pompidou, APHP, Paris, France.

Funding

Association Nationale de la Recherche et de la Technologie 2019/0065
6 · The paper itself

Abstract

aimsThe primary objectives of this study were to analyse the nationwide healthcare trajectories of heart failure (HF) patients in France, 2 years after their first hospitalization, and to measure sequence similarities. Secondary objectives were to identify the association between trajectories and the risk of mortality. METHODS AND

resultsA retrospective, observational study was conducted using data extracted from the Echantillon Généraliste des Bénéficiaires database, covering the period from 1 January 2008 to 31 December 2018. Follow-up concluded upon death or at the end of the study. We developed a methodology specific to healthcare data by extracting frequent healthcare trajectories and measuring their similarity for use in a survival machine learning analysis. In total, 11 488 HF patients were included and followed up for an average of 2.9 ± 1.3 years. The mean age of the patients was 78.0 ± 13.2 years. The first-year mortality rate was 31.7% and increased to 78.8% at 5 years. Fifty per cent of patients experienced re-hospitalization for reasons related to cardiovascular diseases. We identified 1707 hospitalization sequences, and 21 sequences were associated with survival, while 15 sequences were linked to mortality. In all our models, age and gender emerged as the most significant predictors of mortality (permutation feature importance: 0.099 ± 0.00078 and 0.0087 ± 0.00018, respectively; weights could be interpreted in relative terms). Specifically, the age at initial hospitalization for HF was positively associated with mortality. Gender (male: 49.5%) was associated with poorer prognoses. Healthcare trajectories, including non-surgical device treatments, valve replacements, and atrial fibrillation ablation, were associated with a better prognosis (permutation feature importance: 0.0047 ± 0.00011, 0.0014 ± 0.000073, and 0.00095 ± 0.000097, respectively), except in cases where these invasive treatments preceded or followed hospitalization for cardiac decompensation. The predominant negative prognosis sequences were mostly those that included HF-related hospitalizations before or after other-related hospitalizations (permutation feature importance: 0.0007 ± 0.000091 and 0.00011 ± 0.000045, respectively).

conclusionsWe highlight the value of healthcare trajectories on frequent hospitalization sequences, mortality, and prognosis and indicate the necessary prognostic value of HF re-hospitalization. Our work may be an essential tool for better identification of at-risk patients in order to increase and improve personalized care in the future.

Indexed as

Delivery of Health CareHeart FailureAgedAged, 80 and overFemaleFollow-Up StudiesFranceHospitalizationHumansMalePrognosisRetrospective StudiesSurvival RateData miningHealthcare trajectoriesHeart failureMortalityPredictionSequential pattern

Identifiers

PMID38509817
PMCPMC11287304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.